Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
10.90
-0.29 (-2.59%)
Feb 27, 2026, 4:00 PM EST - Market closed
Benitec Biopharma Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Benitec Biopharma stock have an average target of 27.67, with a low estimate of 22 and a high estimate of 32. The average target predicts an increase of 153.85% from the current stock price of 10.90.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 24, 2025.
Analyst Ratings
The average analyst rating for Benitec Biopharma stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $35 → $32 | Strong Buy | Maintains | $35 → $32 | +193.58% | Nov 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $28 → $35 | Strong Buy | Maintains | $28 → $35 | +221.10% | Nov 4, 2025 |
| Citizens | Citizens | Buy Maintains $20 → $22 | Buy | Maintains | $20 → $22 | +101.83% | Nov 4, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $20 | Buy | Reiterates | $20 | +83.49% | Sep 24, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $35 → $29 | Buy | Maintains | $35 → $29 | +166.06% | Sep 16, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
20.42M
EPS This Year
-1.04
from -1.05
EPS Next Year
-1.18
from -1.04
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 105.1M | |
| Avg | n/a | 20.4M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.97 | -1.09 | |
| Avg | -1.04 | -1.18 | |
| Low | -1.18 | -1.21 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.